| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/15/2003 | CN1448135A High potency antiseptic composite medicine |
| 10/15/2003 | CN1448134A Adaptation of anethole trithione for use in prep.of medicine |
| 10/15/2003 | CN1448133A Daphnetin and arteannuin derivative compatible anti-malaria composition |
| 10/15/2003 | CN1448132A Modified antineoplastic preparation based on Paclitaxel |
| 10/15/2003 | CN1448131A Medicine composition containing alpha-pinene and 1,8-eucalyptol fever-tree oil and use thereof |
| 10/15/2003 | CN1448130A Application of curcumin for treating myodystrophy |
| 10/15/2003 | CN1448129A Garlicin and garlic oil cyclodextrin derivatives inclusion compound and method for making same |
| 10/15/2003 | CN1448128A Process for producing nanoparticles of paclitaxel and albumin |
| 10/15/2003 | CN1448123A Non-spherical and non-platelet pyrithione salts |
| 10/15/2003 | CN1124348C Multi-functional hematopoietic receptor agonists |
| 10/15/2003 | CN1124279C Platinum complex, its preparation and therapeutic application |
| 10/15/2003 | CN1124278C Platinum complex, its preparation and therapeutic application |
| 10/15/2003 | CN1124276C Rapamycin derivatives |
| 10/15/2003 | CN1124270C Cyclopentene derivatives useful as antagonists of the motilin receptor |
| 10/15/2003 | CN1124269C Substituted pryimidine compounds and their use |
| 10/15/2003 | CN1124266C Azacyclooctane and heptane derivatives, their preparation and usein therapy |
| 10/15/2003 | CN1124262C Indole derivatives useful as endothelin receptor antagonists |
| 10/15/2003 | CN1124260C Para retinoic acid |
| 10/15/2003 | CN1124258C Substituted dihydropyridine dicarboxylic ester |
| 10/15/2003 | CN1124255C Inhibition of matrix metalloproteases by substituted phenethyl compounds |
| 10/15/2003 | CN1124157C Pharmaceutical compositions |
| 10/15/2003 | CN1124153C Medicinal composition for restoring cardiac collaterals and its application |
| 10/15/2003 | CN1124137C Condensation polymer composition for preventing pregnancy |
| 10/15/2003 | CN1124136C Drug containing methotrexate derivative |
| 10/15/2003 | CN1124135C Use of rapamycin derivatives in vasculopathies and xenotransplantation |
| 10/15/2003 | CN1124134C Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preven |
| 10/15/2003 | CN1124133C Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and pre |
| 10/15/2003 | CN1124132C Antibacterial/bactericidal/antiseptic agent, dermatologic preparation and detergent composition |
| 10/15/2003 | CN1124130C Pharmaceutical preparation comprising colodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| 10/15/2003 | CN1124129C Solid foamed active substance preparations |
| 10/15/2003 | CA2381830A1 Compositions comprising thylakoids useful in the modulation of the inflammation process |
| 10/14/2003 | US6632963 Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 10/14/2003 | US6632962 Caspase inhibitors and uses thereof |
| 10/14/2003 | US6632946 Tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them |
| 10/14/2003 | US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain |
| 10/14/2003 | US6632939 Dissolving in alcohol; synthetic blood |
| 10/14/2003 | US6632933 Use of azetidinone compounds |
| 10/14/2003 | US6632929 Avidin derivatives and uses thereof |
| 10/14/2003 | US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders |
| 10/14/2003 | US6632845 Method for improving muscle control and muscle tone and improving sensory integration |
| 10/14/2003 | US6632843 Treatment of bruxism |
| 10/14/2003 | US6632842 Reducing medication error and enhancing therapeutic compliance of an individual suffering from COPD by providing a single use inhaler |
| 10/14/2003 | US6632841 Not in the form of cyclodextrin inclusion complex; in solution with lactic acid as solubilizer |
| 10/14/2003 | US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them |
| 10/14/2003 | US6632838 Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia |
| 10/14/2003 | US6632837 Administered once daily for treatment of neoplastic condition |
| 10/14/2003 | US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like |
| 10/14/2003 | US6632834 Compositions and methods for treating conditions responsive to estrogen |
| 10/14/2003 | US6632832 Inhibiting epidermal growth factor dependent proliferation in cancer cells |
| 10/14/2003 | US6632831 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases |
| 10/14/2003 | US6632830 ACE-2 inhibiting compounds and methods of use thereof |
| 10/14/2003 | US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases |
| 10/14/2003 | US6632828 Substituted imidazole neuropeptide Y Y5 receptor antagonists |
| 10/14/2003 | US6632827 Compositions of optically pure (+) norcisapride |
| 10/14/2003 | US6632826 Carbocyclic HIV protease inhibitors |
| 10/14/2003 | US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives |
| 10/14/2003 | US6632824 Have the ability to act at the 5-HT transporter. |
| 10/14/2003 | US6632823 Substituted pyridine compounds useful as modulators of acetylcholine receptors |
| 10/14/2003 | US6632822 Compounds and therapeutic methods |
| 10/14/2003 | US6632821 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 10/14/2003 | US6632820 Anticancer agents |
| 10/14/2003 | US6632819 Antiviral azaindole derivatives |
| 10/14/2003 | US6632818 Inhibitors of prenyl-protein transferase |
| 10/14/2003 | US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors |
| 10/14/2003 | US6632813 6-subtituted-7-heteroquinoxalinecarboxylic acid derivatives and addition salts thereof and processes for the preparation of both |
| 10/14/2003 | US6632812 Substituted lactams as inhibitors of Aβ protein production |
| 10/14/2003 | US6632811 Administering cycloalkyl, lactam, lactone compounds for for inhibiting beta -amyloid peptide release and/or its synthesis in a cell |
| 10/14/2003 | US6632810 Cyclic diamine compound with condensed-ring groups |
| 10/14/2003 | US6632809 Gyrase inhibitors and uses thereof |
| 10/14/2003 | US6632808 Alzheimer's disease and type 2 diabetes |
| 10/14/2003 | US6632807 (2R,4S)-(−)-[N-(4-diethoxyphosphorylmethyl)phenyl]-1,2,4,5- tetrahydro-4-methyl-7,8-methylenedioxy-5-oxo-3-benzothiepin-2-carboxamide |
| 10/14/2003 | US6632806 Administering compound having selective GABAc receptor antagonist activity |
| 10/14/2003 | US6632804 Therapeutically effective amount of ferrous ion and a therapeutically effective amount of an ascorbate |
| 10/14/2003 | US6632803 Pharmaceutical formulations containing voriconazole |
| 10/14/2003 | US6632801 Method and composition for inhibiting human cholesterol esterase |
| 10/14/2003 | US6632799 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 10/14/2003 | US6632798 Methods for inhibiting angiogenesis |
| 10/14/2003 | US6632797 Administering to a mammal a cyclic compound (acyclic, carbocyclic or heterocyclic) substituted by at least three vicinal phosphorus containing radicals for treating angiogenesis in tumor conditions |
| 10/14/2003 | US6632796 Pharmaceutical compositions for promoting the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof |
| 10/14/2003 | US6632795 Treatment of cancer |
| 10/14/2003 | US6632794 Insulin-like growth factor agonist molecules |
| 10/14/2003 | US6632789 Contacting with inhibitor or activator of phosphatidylinositol 3-kinase |
| 10/14/2003 | US6632671 Nanoparticle encapsulation system and method |
| 10/14/2003 | US6632667 Using a antisense oligonucleotides targeted to a untranslated region or a stop codon region of a nucleic acid; use in treatment of Crohn's disease, diabetes, multiple sclerosis, rheumatoid arthritis, hepatitis, pancreatitis and asthma |
| 10/14/2003 | US6632664 Foreign gene inserted into an untranslated region in the genome |
| 10/14/2003 | US6632648 Methods of terminal sterilization of fibrinogen |
| 10/14/2003 | US6632460 Treating angina pectoris, reducing the usage of nitroglycerin |
| 10/14/2003 | US6632459 For prophylaxis and therapy of diseases, infections |
| 10/14/2003 | US6632455 Molecular dispersion composition with enhanced bioavailability |
| 10/14/2003 | US6632454 Multilayer pharmaceutical product for release in the colon |
| 10/14/2003 | US6632453 Ciprofoxacin-metronidazole antibiotic composition |
| 10/14/2003 | US6632452 Medicinal compositions retarded in the discoloration of phenolic hydroxyl compounds |
| 10/14/2003 | US6632449 Compositions and kits comprising a defined boron compound and methods of their preparation |
| 10/14/2003 | US6632447 Estrogen receptor modulator (SERM): Tamoxifen Citrate and Raloxifene, and Faslodex (Antiestrogen), reducing the amount of high grade prostate intraepithelial neoplasia lesions |
| 10/14/2003 | US6632443 Water-soluble compositions of bioactive lipophilic compounds |
| 10/14/2003 | US6632441 Mutants of streptococcal toxin a and methods of use |
| 10/14/2003 | US6632430 Administering enzyme inhibitors of S-adenosyl methionine synthetase (SAMS), of S-adenosyl homocysteine hydrolase (SAHH) and of transmethylases, RNA transmethylase and DNA transmethylase; antidotes; detoxification |
| 10/14/2003 | US6632428 Hyperlipidemia, lowering both the serum cholesterol and serum triglyceride levels, culturing a Lovastatin-producing Monascus strain |
| 10/14/2003 | US6632423 To prevent or reduce fibrosis and/or adhesion in traumatized tissues, comprising the administration of a stabilizing effective amount of the agent to the traumatized tissue |
| 10/14/2003 | US6632419 Increasing libido in humans via acute testosterone administration |